Neurobiological Technologies (Neurobiological Technologies) Cash Ratio : 40.44 (As of Sep. 2009)

Neurobiological Technologies Cash Ratio Chart

Neurobiological Technologies Annual Data
	Trend	Jun00	Jun01	Jun02	Jun03	Jun04	Jun05	Jun06	Jun07	Jun08	Jun09
Cash Ratio		Get a 7-Day Free Trial					2.23	1.59	0.63	3.32	21.57

Neurobiological Technologies Quarterly Data
	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09
Cash Ratio	Get a 7-Day Free Trial															2.80	1.66	1.78	21.57	40.44

Competitive Comparison of Neurobiological Technologies's Cash Ratio

For the Biotechnology subindustry, Neurobiological Technologies's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurobiological Technologies's Cash Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neurobiological Technologies's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Neurobiological Technologies's Cash Ratio falls into.

Neurobiological Technologies Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Neurobiological Technologies's Cash Ratio for the fiscal year that ended in Jun. 2009 is calculated as:

Neurobiological Technologies's Cash Ratio for the quarter that ended in Sep. 2009 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurobiological Technologies  (OTCPK:NTII) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.

Neurobiological Technologies Cash Ratio Related Terms

Thank you for viewing the detailed overview of Neurobiological Technologies's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurobiological Technologies (Neurobiological Technologies) Business Description